Peripheral endocannabinoid system dysregulation in first-episode psychosis.

Author(s): Bioque M, García-Bueno B, Macdowell KS, Meseguer A, Saiz PA, Parellada M, Gonzalez-Pinto A, Rodriguez-Jimenez R, Lobo A, Leza JC, Bernardo M; FLAMM-PEPs study—Centro de Investigacio´n Biome´dica en Red de Salud Mental

Schizophrenia Clinic Unit, Neuroscience Institute, Hospital Clínic de Barcelona, Barcelona, Spain

Subject: Schizophrenia View the study

Abstract:

Several hypotheses involving alterations of the immune system have been proposed among etiological explanations for psychotic disorders. The endocannabinoid system (ECS) has a homeostatic role as an endogenous neuroprotective and anti-inflammatory system. Alterations of this system have been associated with psychosis. Cannabis use is a robust risk factor for these disorders that could alter the ECS signalling. In this study, 95 patients with a first episode of psychosis (FEP) and 90 healthy controls were recruited.

Source: Neuropsychopharmacology
Share Tweet

More medical studies related to Schizophrenia:

View all medical studies >>

Subscribe for daily cannabis news, announcements, and business insights.

мицубиси асх цена

узнать больше poliv.ua

www.ry-diplomer.com/diplomy-v-orle